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Detecting transcription of ribosomal protein
pseudogenes in diverse human tissues from
RNA-seq data
Peter Tonner1, Vinodh Srinivasasainagendra2, Shaojie Zhang1* and Degui Zhi2*
Abstract
Background: Ribosomal proteins (RPs) have about 2000 pseudogenes in the human genome. While anecdotal
reports for RP pseudogene transcription exists, it is unclear to what extent these pseudogenes are transcribed. The
RP pseudogene transcription is difficult to identify in microarrays due to potential cross-hybridization between
transcripts from the parent genes and pseudogenes. Recently, transcriptome sequencing (RNA-seq) provides an
opportunity to ascertain the transcription of pseudogenes. A challenge for pseudogene expression discovery in
RNA-seq data lies in the difficulty to uniquely identify reads mapped to pseudogene regions, which are typically
also similar to the parent genes.
Results: Here we developed a specialized pipeline for pseudogene transcription discovery. We first construct a
“composite genome” that includes the entire human genome sequence as well as mRNA sequences of real
ribosomal protein genes. We then map all sequence reads to the composite genome, and only exact matches were
retained. Moreover, we restrict our analysis to strictly defined mappable regions and calculate the RPKM values as
measurement of pseudogene transcription levels. We report evidences for the transcription of RP pseudogenes in
16 human tissues. By analyzing the Human Body Map 2.0 study RNA-sequencing data using our pipeline, we
identified that one ribosomal protein (RP) pseudogene (PGOHUM-249508) is transcribed with RPKM 170 in thyroid.
Moreover, three other RP pseudogenes are transcribed with RPKM> 10, a level similar to that of the normal RP
genes, in white blood cell, kidney, and testes, respectively. Furthermore, an additional thirteen RP pseudogenes are
of RPKM> 5, corresponding to the 20–30 percentile among all genes. Unlike ribosomal protein genes that are
constitutively expressed in almost all tissues, RP pseudogenes are differentially expressed, suggesting that they may
contribute to tissue-specific biological processes.
Conclusions: Using a specialized bioinformatics method, we identified the transcription of ribosomal protein
pseudogenes in human tissues using RNA-seq data.
Keywords: Ribosomal protein, Pseudogene, Transcription, RNA-seq data
Background
Pseudogenes are “fossil” copies of functional genes that
have lost their potential as DNA templates for functional
products [1-6]. While the definition of pseudogenes is
still somewhat fuzzy, most of them are defined oper-
ationally by bioinformatics criteria, e.g., genomic scans
of signatures of homology to known genes. Ribosomal
protein (RP) pseudogenes represent the largest class of
pseudogenes found in the human genome: over 2000
ribosomal protein pseudogenes are identified by bio-
informatics scan of genomic sequence [5].
These pseudogenes are commonly thought to be non-
functional due to the lack of promoters and/or the pres-
ence of loss of function mutations. Indeed, the vast
majority of these pseudogenes either carry dysfunctional
mutations such as in-frame stop codons, or lack of
proper regulatory sequences, such as promoters, mTOP
signals, and first introns [7]. Interestingly, three RP
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pseudogenes, with 89%-95% sequence identity to their
parent (progenitor) RP genes, were found to be tran-
scribed and seem to be functional, by a bioinformatics
scan of cDNA and expression sequence tag (EST) data-
bases and confirmation by PCR and Northern blot [8]. A
genome-wide bioinformatics scan identified over 2000
potential pseudogenes [5]. Moreover, it was found [9]
that the six RP pseudogenes shared at syntenic loci be-
tween the human and the mouse genomes are more
conserved than other RP pseudogenes.
However, data were lacking to experimentally validate
pseudogene expression. It is unclear from the literature
whether the reported cases are merely anecdotal or that
pseudogenes do play some cellular roles. This is largely
hindered by the lack of methods for the identification of
pseudogenes transcription. The traditional method of
transcriptome profiling, gene expression microarray, is
not sensitive in distinguishing transcripts among very
similar gene sequences.
Recent advancements of next-generation sequencing
allow for direct massive transcriptome sequencing
(RNA-seq), and thus providing unprecedented insights
into all transcribed sequences. For example, RNA-seq
has been applied to detect complex transcriptional activ-
ities such as alternative splicing [10,11] and allelic-
specific expression [12]. Recently, RNA-seq has been
applied to reveal RNA editing events [13]. However, to the
best of our knowledge, there were yet no attempts to de-
tect the transcription of pseudogenes in RNA-seq data.
The main challenge for pseudogene identification in
RNA-seq data is the difficulty of high fidelity read map-
ping. Because sequences of pseudogenes are highly similar
to the sequences of the mRNAs of the parent genes, spe-
cialized read mapping methods are required to detect
reads unambiguously generated from pseudogenes.
In this study, we conduct a bioinformatics analysis of
pseudogene expression using RNA-sequencing data of 16
human tissues of the Illumina Human Body Map 2.0 pro-
ject. We first describe our new computational pipeline for
detecting pseudogene expression that disentangles se-
quencing reads of pseudogenes from those of the parent
genes, with consideration of possible mismatches due to
SNPs and RNA-editing. This is followed by a description
of our findings and a discussion of their implications.
Results
Illumina Human Body Map 2.0 RNA-seq data
The Human Body Map 2.0 Project by Illumina generated
RNA-seq data for 16 different human tissues (adipose,
adrenal, brain, breast, colon, heart, kidney, liver, lung,
lymph node, ovary, prostate, skeletal muscle, testes, thy-
roid, and white blood cells). In our analysis we used the
75 bps single read data, with one lane of HiSeq 2000
Table 1 The number of reads mapped to RefSeq sequences and RP pseudogenes for both the composite genome and
the unaltered human genome (hg18) for each tissue
Tissue RP Pseudogenes RefSeq Sequences
Composite genome hg18 Ratio Composite genome hg18 Ratio
Adipose 708 22613 0.03 22018081 23753007 0.93
Adrenal 2439 22280 0.11 19436010 21074345 0.92
Brain 712 3853 0.18 11585759 12357788 0.94
Breast 1603 15951 0.10 22962845 23060856 1.00
Colon 1066 22948 0.05 21458813 21618780 0.99
Heart 562 2374 0.24 12622175 13502482 0.93
Kidney 1341 5928 0.23 20630500 22278600 0.93
Liver 328 2359 0.14 16689110 17958332 0.93
Lung 1128 11918 0.09 28648503 31274037 0.92
Lymph 1456 14010 0.10 22126747 23998836 0.92
Muscle 459 8705 0.05 25836676 27662752 0.93
Ovary 1501 34608 0.04 21842763 23663484 0.92
Prostate 1280 14976 0.09 30329651 32822472 0.92
Testes 1885 19417 0.10 23356973 25123824 0.93
Thyroid 4064 22250 0.18 24800037 26627946 0.93
White Blood Cells 1095 14256 0.08 25487259 27812790 0.92
Average 1351 14902 0.11 21864493 23411895 0.94
The ratio is calculated by the number of mapped reads from the composite genome over the number of mapped reads from the unaltered human genome
(hg18).
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data per tissue. Standard mRNA-seq library preps were
used to extract poly-A selected mRNAs.
Discovery of pseudogene transcription in RNA-seq data
Our primary goal is to detect transcriptional activities of
any of the 1709 processed RP pseudogenes. In addition,
we also want to provide a preliminary quantification of
their level of transcription.
We developed a novel bioinformatics approach for
detecting the subtle signals of pseudogene expression.
Briefly, we first compiled a “composite genome” consisting
of known RP gene spliced mRNA sequences and the
human genome (hg18) [14]. We then mapped RNA-seq
reads to the composite genome using Bowtie [15], allowing
no mismatches and discarding reads mapped to more than
one locus. Thus we ensured that the reads mapped to RP
pseudogenes are neither from repetitive regions nor from
normal RP genes. On average 89% of the reads aligning to
RP pseudogenes can also be mapped to real RP spliced
mRNA sequences and are removed when mapped to the
composite genome (see Table 1). Furthermore, to remove
mapped reads that may be caused by SNPs and RNA-
editing, we extended the concept of the mappability (the
mappable regions of human genome is called the
uniqueome) [16] and masked regions in RP pseudogenes
that are duplicated in the composite genome within 4 mis-
matches over the 75 bps read length. The number of reads
we removed from non-unique locations in both the com-
posite genome and hg18 genome can be seen in Table 2.
The mappability regions only correspond to the unaltered
human genome locations, so all reads mapped to RP gene
mRNA sequences in the composite genome are removed
during this step. Additionally, the composite genome align-
ment lacks the reads that mapped both to the unaltered
human genome locations and spliced RP gene mRNA
sequences as we only retained reads aligning to a single lo-
cation. With both of these groups of reads removed, the
number of reads mapped uniquely in the composite gen-
ome is always less than that in the unaltered human gen-
ome. Finally, we calculated the transcription levels, as
measured by the Reads Per Kilobase per Million reads
(RPKM) [11] of all pseudogenes according to the mapped
reads in their mappable regions. As a benchmark for nor-
mal expression levels, we also aligned reads to an unaltered
genome using TopHat and measured FPKM of all RefSeq
genes using Cufflinks [17]. The alignment information of
reads to the composite genome, and to the unaltered gen-
ome (hg18), can be seen in Table 2. Please see Methods for
details.
Prevalent transcription of RP pseudogenes
The expression levels of the top seventeen highly
expressed ribosomal protein pseudogenes in 16 human
tissues are shown in Figure 1 and Table 3 (See Table S1
Table 2 Statistics for each tissue sample
Tissue Number of
reads in the
sample
Number of
reads mapped
to the
composite
genome
Number of
reads
mapped to
hg18
Number of reads
mapped uniquely
to the composite
genome
Number of
reads mapped
uniquely to the
hg18
Adipose 76,269,225 39,499,413 39,759,404 27,507,408 30,635,265
Adrenal 76,171,569 39,330,423 39,681,721 29,670,249 32,603,673
Brain 64,313,204 21,022,913 21,073,103 15,785,362 17,187,772
Breast 77,195,260 39,355,808 39,568,435 30,955,674 31,072,723
Colon 80,257,757 39,406,195 39,735,900 28,393,105 28,582,515
Heart 76,766,862 29,030,896 29,065,063 17,099,881 19,366,541
Kidney 79,772,393 41,368,095 41,488,175 27,316,562 30,570,744
Liver 77,453,877 26,692,219 26,741,073 18,897,673 20,715,729
Lung 81,255,438 45,996,752 46,211,355 34,401,958 37,862,617
Lymph 81,916,460 41,826,888 42,072,585 30,451,248 33,277,288
Muscle 82,864,636 46,580,440 46,725,392 30,704,302 34,165,828
Ovary 81,003,052 36,922,138 37,385,453 28,184,877 30,861,571
Prostate 83,319,902 47,601,661 47,965,443 36,138,822 39,533,973
Testes 82,044,319 38,852,709 39,069,136 29,115,004 31,927,737
Thyroid 80,246,657 40,546,781 40,785,090 31,137,501 33,939,339
White Blood Cells 82,785,673 38,860,771 39,098,752 28,796,204 31,784,122
The number of reads mapped to the composite genome (which includes spliced ribosomal protein gene sequences) and to the unaltered human genome (hg18),
and the number of reads overlapped with uniqueome (“mapped uniquely”) for both are shown. For the composite genome, the number of reads aligning to the
entire composite genome and the unaltered hg18 human genome are shown.
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in Additional file 1 for complete list for all RP pseudo-
genes). As expected the majority of pseudogenes have
no reads aligning to their sequence. Interestingly, there
were some pseudogenes with high expression levels.
One RP pseudogene (PGOHUM-249508) is transcribed
with RPKM 170 in thyroid. Moreover, three additional
RP pseudogenes are transcribed with RPKM>10. Fur-
thermore, thirteen more RP pseudogenes are of RPKM>5.
We describe pseudogenes with an RPKM>10 as “highly
expressed”, with the understanding that they may be
only representing the top 10–15 percentile of all 37,681
RefSeq genes in the Human Body Map 2.0 data set,
while RPKM> 5 represents the top 20–30 percentile
(see Table 4). Below we discuss these cases in detail.
PGOHUM-249508, an RPL21 pseudogene, is expressed
with RPKM=170 in thyroid (Figure 2). This highest
expressed RP pseudogene is located in an intron of the
Thyroglobulin (TG) gene. The TG gene is highly and spe-
cifically expressed in the same tissue, thyroid, and the gene
encodes a glycoprotein that acts as a substrate for the
synthesis of thyroxine and triiodothyronine as well as the
storage of the inactive forms of thyroid hormone and iod-
ine [18]. The transcription of this pseudogene goes beyond
the annotated pseudogene region, but is less than the en-
tire intron region. Although the pseudogene is specifically
expressed in the same tissue as TG, the RP coding frame
is on the reverse strand of the TG gene. Therefore, it is
possible that this pseudogene is on a distinct transcript
other than the TG gene. Moreover, according to UCSC
genome browser [19], this pseudogene region is only
conserved within the primates (between human and the
Rhesus monkey), but not in other mammalian and verte-
brate lineages. As a side note, the genome browser shows
a peculiar conservation pattern between human and the
stickleback fish, but it is likely to be an artifact of match-
ing human genomic sequence with the RPL21 gene of
stickleback fish.
Three additional pseudogenes are highly transcribed
(RPKM>10). PGOHUM-237215, an RPL7A pseudogene,
is expressed RPKM=17 in white blood cells. This
Figure 1 RPKM of RP pseudogenes. See Table S1 in Additional file 1 for the complete list.
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pseudogene is located in an intergenic region. Also, the
transcription unit seems to span a longer region
(Figure 3). It is transcribed in a white blood cell specific
fashion. PGOHUM-249146, an RPS24 pseudogene, is
expressed in kidney. This pseudogene is located in the in-
tronic region of gene SLC12A3 (Figure 4). This gene
encodes a renal thiazide-sensitive sodium-chloride
cotransporter that is important for electrolyte homeosta-
sis. PGOHUM-239833, an RPS11 pseudogene, is
expressed in testes. This pseudogene is located in an inter-
genic region (Figure 5). The comparison of read coverage
with or without uniqueome filtering for these four RP
pseudogenes can be been in Figures S1-S4 in Additional
file 2.
Table 3 RP pseudogenes expression identified in Human Body Map 2.0 RNA-seq data
pg-id Parent gene Location Tissue with Max RPKM Max RPKM Total RPKM Tissue specificity Reads coverage
249508 RPL21 chr8:134084035-134084502 Thyroid 170.3 170.6 0.977 0.976
237215 RPL7A chr17:6984988-6985635 White Blood Cells 17.3 18.0 0.881 0.913
249146 RPS24 chr16:55497947-55498335 Kidney 16.5 17.6 0.855 0.693
239833 RPS11 chr12:63076580-63077044 Testes 11.3 12.5 0.813 0.970
236635 RPL24 chr9:72021934-72022269 Colon 9.7 9.7 1.000 0.358
248697 RPL26 chr16:1953719-1954097 Lymph 9.0 37.9 0.376 0.854
242376 RPS20 chr11:77202016-77202370 Colon 8.6 41.6 0.355 1.00
251340 RPLP1 chr5:151125656-151125993 Testes 7.4 40.1 0.339 0.567
237777 RPL7 chr3:133445060-133445787 Prostate 7.3 8.0 0.819 0.371
234492 RPL10 chr19:9791817-9792131 Brain 7.2 10.8 0.635 0.121
248932 RPL21 chr16:72904438-72904782 Ovary 6.5 34.3 0.343 1.00
234407 RPL39 chr19:58143205-58143330 Colon 6.3 21.3 0.414 1.00
239633 RPL13 chr12:6863424-6864038 Kidney 6.0 27.0 0.365 0.923
245936 RPL6 chr4:66121772-66122638 Colon 5.9 7.2 0.746 0.109
243590 RPL32 chr6:33155206-33155612 Adrenal 5.8 9.2 0.617 1.00
241074 RPL13A chr2:203093361-203093957 Lung 5.4 9.7 0.571 0.995
238877 RPL11 chr10:89695235-89695766 Adipose 5.2 20.4 0.387 0.847
Expression levels of pseudogenes with their pseudogene ID (pg-id, prefix ‘PGOHUM00000’ omitted) are measured in terms of RPKM. Only pseudogenes with
maximum RPKM>5 are shown. Tissue specificities are measured by the JS divergence [20]. Read coverage is the ratio of pseudogene exon length covered by
uniquely mapped reads to the total pseudogene exon length.
Table 4 Table of FPKM expression values of RefSeq genes in 16 human tissues
Tissue FPKM Percentile
Mean Max Min std dev %>1 %>2 %>5 %>10 %>15
Adipose 10.03 17437.80 0 143.53 41.07 32.42 20.62 12.64 8.96
Colon 10.42 17376.90 0 167.07 40.80 31.61 19.67 11.93 8.37
Heart 7.55 17376.90 0 122.87 36.61 27.71 16.09 9.41 6.43
Kidney 9.97 16400.20 0 156.94 45.28 35.93 22.62 13.32 9.23
Liver 14.91 38505.10 0 360.25 33.57 25.10 14.90 8.93 6.48
Lung 16.29 57096.60 0 456.70 44.59 35.08 22.05 13.61 9.72
Lymph 13.41 40919.80 0 337.50 45.77 36.77 23.25 13.70 9.22
Muscle 8.80 16317.70 0 123.85 33.27 25.97 16.38 10.39 7.55
Ovary 13.62 61099.30 0 359.00 46.27 37.60 24.59 15.05 10.37
Prostate 13.72 39039.90 0 300.91 47.82 38.83 25.36 15.68 10.79
Testes 12.76 57096.60 0 325.41 53.34 43.44 28.69 17.85 12.46
Thyroid 12.06 29030.10 0 234.59 46.04 37.25 24.24 15.12 10.74
White Blood Cells 15.42 40919.80 0 366.35 39.25 32.56 22.65 14.87 10.83
All Tissues 12.23 61099.30 0 286.98 42.59 33.87 21.62 13.27 9.32
Percentile columns represent the percentage of RefSeq genes in all tissues with FPKM above a given value.
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Tissue-specificity of pseudogene transcription
Many genes are expressed in a tissue-specific fashion.
The Human Body Map 2.0 data allow us to study the
tissue-specificity of transcriptions of these pseudogenes.
We adopt the entropy-based Jensen-Shannon (JS) diver-
gence measure used in [20]. The distributions of tissue-
specificity JS divergences of RP pseudogenes versus RP
genes are shown in Figure 6. In the Human Body Map
2.0 data set, all RP genes are not transcribed in a tissue
specific fashion (JS divergence <0.5 for all RP genes)
(Table S2 in Additional file 3). Unlike ribosomal protein
genes that are constitutively expressed in almost all tis-
sues, many RP pseudogenes are differentially expressed
(Table S1 in Additional file 1). Among the seventeen
pseudogenes with RPKM>5 at some tissue, 8 of them
have a JS divergence > 0.5. In fact, all of the top 4 pseu-
dogenes with RPKM>10 are transcribed in a highly tis-
sue specific fashion (JS divergence > 0.8). These results
suggest that these highly expressed RP pseudogenes may
contribute to tissue-specific biological processes.
Discussion and conclusions
In this work, we conducted a bioinformatics analysis of
the pseudogenes of ribosomal protein genes in diverse
human tissues. Using our specialized pipeline, we identi-
fied several cases of pseudogene expression. Most not-
ably, one pseudogene in an intron of the TG gene is
extremely highly expressed in thyroid. Moreover, several
other pseudogenes are also highly expressed. We found
that many pseudogenes are expressed in a tissue-specific
fashion. Also, the expression of pseudogenes seems to
often go beyond the boundaries of the annotated pseu-
dogenes. Apparently, further experimental investigations
will be needed to reveal the biological relevance of these
expressions.
Transcriptome sequencing, RNA-seq, provides an un-
precedented opportunity to uncover many complexities
of cellular gene expression. A key computational chal-
lenge in RNA-seq data analysis is to discern reads among
multiple potential sources with similar sequences. In this
work we focused on the detection of evidences of
Scale
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Figure 2 UCSC browser view of RNA-seq expression of pseudogene PGOHUM-249508 in Thyroid. RPKM= 170, Tissue Specificity = 0.977.
Open reading frames (ORFs) in +1, +2, +3, -1, -2, and −3 are annotated.
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pseudogene expression. We used extremely strict read
mapping criteria to minimize potential false positives.
Admittedly we did not utilize all potential reads, especially
at regions with low uniqueness. Further research may con-
sider using looser mapping criteria combined with sophis-
ticated statistical algorithms to take into account the
mapping ambiguity.
The bioinformatics methods presented here may find
application in other RNA-seq studies dealing with high
similarity in reference sequences. In particular, the same
methodology may be able to identify differential expres-
sion between other homologous genome regions. Stud-
ies in other fields, such as metagenomics, dealing with
high similarity DNA sequences may also find benefits
from strict alignment and intersection with uniquely
mappable locations.
Methods
Human tissue samples
The Human Body Map 2.0 RNA-seq data for 16 human tis-
sue samples were provided by Gary Schroth at Illumina
and can be accessible from ArrayExpress (accession no. E-
MTAB-513). Reads were 75 base pairs long and came from
the following samples: adipose, adrenal, brain, breast, colon,
heart, kidney, liver, lung, lymph, muscle, ovary, prostate,
testes, thyroid, and white blood cells. The samples were
prepared using the Illumina mRNA-seq kit. They were
made with a random priming process and are not stranded.
Software and datasets
Bowtie version 0.12.7 [15] and TopHat version 1.2.0 [21]
were used for the mapping. Cufflinks version 1.0.3 [17]
was used for differential expression calculation for
Figure 3 UCSC browser view RNA-seq expression of pseudogene PGOHUM-237215 in white blood cells. RPKM= 17, Tissue
Specificity = 0.881. Open reading frames (ORFs) in +1, +2, +3, -1, -2, and −3 are annotated.
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RefSeq genes. BEDTools version 2.12.0 [22] was used to
analyze alignments. The uniqueome dataset was col-
lected from the Uniqueome supplementary database [16]
for human genome (hg18, NCBI Build 36.1) marking
genome locations where reads of length 75 bps
are unique within 4 mismatches (hg18_uniqueome.
unique_starts.base-space.75.4.positive.BED). The 75 bps
read length matches the RNA-seq data provided by Illu-
mina. RefSeq genes and DNA sequences of spliced ribo-
somal protein genes were collected from NCBI (RefSeq
database D32-6) [14]. Pseudogene annotations and
sequences were downloaded from pseudogene.org [23]
database (human pseudogenes build 58). Pseudogenes
whose parent genes are ribosomal protein genes were
selected, totaling 1788. Among them, 79 were annotated
‘Duplicated’. As we are only interested in processed
pseudogenes, our analysis focuses on the remaining
1709 pseudogenes. The human genome sequence (hg18)
was collected from NCBI build 36.1.
Composite genome
A composite genome index was constructed with Bowtie-
build using the sequences of the human genome (hg18,
NCBI build 36.1) and NCBI spliced RP gene sequences.
Alignment
RNA-seq data for each tissue was aligned using two distinct
methodologies – one for pseudogenes and one for real
Figure 4 UCSC browser view RNA-seq expression of pseudogene PGOHUM-249146 in kidney. RPKM= 16, Tissue Specificity = 0.855. Open
reading frames (ORFs) in +1, +2, +3, -1, -2, and −3 are annotated.
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genes. Pseudogene alignment protocol consists of strict
alignment (Bowtie, no mismatches, report reads with only
one alignment location only) to the composite genome.
Real gene alignment protocol consists of strict alignment
(Bowtie, no mismatches, single alignment location) to the
human genome (hg18, NCBI Build 36.1).
Uniqueome
A uniqueome data set [16] was obtained for Build 36.1
marking genome locations where reads of length 75 bps
are unique within 4 mismatches. Alignments for all tis-
sues for both real genes and pseudogenes were inter-
sected with the uniqueome dataset for all genome
locations (intersectBed from BEDTools [22]). The total
number of remaining reads in each alignment was
counted. The uniqueome dataset was used to filter out
ambiguously mapped reads.
Comparative expression analysis
Gene expression values were calculated as reads
aligned to gene per kilobase of exon per million
mapped reads (RPKM) [11]. The number of reads
aligned to all gene exons and additionally aligning in
unique locations was counted for each gene. Exon
length for genes was calculated as the sum of unique
positions as marked by the uniqueome across all gene
exons. It is worth noting that RP pseudogenes appear
spliced in the human genome and therefore have only
Figure 5 UCSC browser view RNA-seq expression of pseudogene PGOHUM-239833 in testes. RPKM= 11, Tissue Specificity = 0.813. Open
reading frames (ORFs) in +1, +2, +3, -1, -2, and −3 are annotated.
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a single exon for counting aligned reads and calculat-
ing exon length.
Expression percentiles of RefSeq genes were calculated
using TopHat to map reads to the human genome (hg18,
NCBI build 36.1) and Cufflinks was used to calculate
FPKM values of all 37,681 RefSeq genes. Expression per-
centiles were calculated for specific tissues and for all
datasets combined.
Gene reads coverage was calculated using the covera-
geBed program in the BEDTools software suite. Coverage
represents the fraction of RP pseudogene exon covered by
reads that aligned to unique genome regions.
Tissue-specificity analysis
We followed the definition of Jensen-Shannon diver-
gence in [20]. To avoid zero probabilities, all RPKM
numbers are added by 10-10.
Additional files
Additional file 1: Table S1. RPKM expression values of RP pseudogenes
in all 16 tissues.
Additional file 2: Figure S1-S4. Comparison of read coverage with or
without uniqueome filtering for four RP pseudogenes.
Additional file 3: Table S2. RPKM expression values of RP genes in all
16 tissues.
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